RSV vaccine uptake will start slower than shingles shot: GSK CEO

GSK Upgrades Long-Term Outlook After Q4 Performance, Shingrix Vaccine And Newly Launched RSV Vaccine Shine

What You Should Know About the Shingrix Vaccine for Shingles Prevention

SEC Filing

GSK says its RSV vaccine for older adults gives long-term protection

424B4

New RSV Vaccines Aren't Covered by Some Health Insurance Plans - The New York Times

GSK plc: An Undervalued Vaccine Behemoth That Is Resuming Growth; Buy (GSK)

A Surprising Finding Leads to an RSV Vaccine Breakthrough - Bloomberg

CNBC Transcript: GSK CEO Emma Walmsley Speaks with CNBC's Jim Cramer Live During CNBC's Healthy Returns Summit Today - CNBC Events

RSV vaccine uptake will start slower than shingles shot: GSK CEO

RSV vaccine uptake will start slower than shingles shot: GSK CEO

What will it take to make an effective vaccine for COVID-19?

Shingrix Archives - PharmaLive

GSK CEO says RSV vaccine revenue to top 1 bln pounds in first year

Moderna's RSV shot efficacy wanes faster than GSK's Arexvy